Current Neuro-Oncology

Volume 24 Number 21
15 November 2022

Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 21, 15 November

Teng Y, Chen C, Zhang Y, Xu J.
The feasibility of MRI texture analysis in distinguishing glioblastoma, anaplastic astrocytoma and anaplastic oligodendroglioma.
Transl Cancer Res. 2022 Nov;11(11):4079-4088
. doi: 10.21037/tcr-22-1390. PMID: 36523299. Observational study. ˍ

Wang E, Gutkin PM, Oh J, Pollom E, Soltys SG, Grant GA, Prolo LM, Chang S, Li G, Fisher PG, Partap S, Campen CJ, Gibbs IC, Hiniker SM.
Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity.
Neurosurg Focus. 2022 Nov;53(5):E2. doi: 10.3171/2022.8.FOCUS22361. PMID: 36321285. Observational study. ˍ

Chen X, Momin A, Wanggou S, Wang X, Min HK, Dou W, Gong Z, Chan J, Dong W, Fan JJ, Xiong Y, Talipova K, Zhao H, Chen YX, Veerasammy K, Fekete A, Kumar SA, Liu H, Yang Q, Son JE, Dou Z, Hu M, Pardis P, Juraschka K, Donovan LK, Zhang J, Ramaswamy V, Selvadurai HJ, Dirks PB, Taylor MD, Wang LY, Hui CC, Abzalimov R, He Y, Sun Y, Li X, Huang X.
Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity.
Neuron. 2022 Nov 1, 2022:S0896-6273(22)00911-4. doi: 10.1016/j.neuron.2022.10.007. PMID: 36323321. Laboratory investigation. ˍ

Liu Y, Chen H, Li G, Zhang J, Yao K, Wu C, Li S, Qiu X.
Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas.
Cancer Biol Med. 2022 Nov 1;19(10):1477–86. doi: 10.20892/j.issn.2095-3941.2022.0472. PMID: 36350001. Observational study. ˍ

Fernandez-Gil BI, Otamendi-Lopez A, Bechtle A, Vazquez-Ramos CA, Qosja N, Suarez-Meade P, Sarabia-Estrada R, Jentoft ME, Guerrero-Cázares H, Escames G, Schiapparelli P, Quiñones-Hinojosa A.
Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma.
Cells. 2022 Nov 2;11(21):3467. doi: 10.3390/cells11213467. PMID: 36359862. Laboratory investigation. ˍ

Mohammed S, Dinesan M, Ajayakumar T.
Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study.
Rep Pract Oncol Radiother. 2022 Nov 2;27(6):1026-1036
. doi: 10.5603/RPOR.a2022.0113. PMID: 36632307. Observational study. ˍ

Smith K, Nakaji P, Thomas T, Pinnaduwage D, Wallstrom G, Choi M, Zabramski J, Chen C, Brachman D.
Safety and patterns of survivorship in recurrent GBM following resection and surgically targeted radiation therapy: Results from a prospective trial.
Neuro Oncol. 2022 Nov 2;24(S6):S4-S15. doi: 10.1093/neuonc/noac133. PMID: 36322102. Interventional study. ˍ

Forster MT, Hug M, Geissler M, Voss M, Weber K, Hoelter MC, Seifert V, Czabanka M, Steinbach JP.
Outcome and characteristics of patients with adult grade 4 diffuse gliomas changing sites of treatment.
J Cancer Res Clin Oncol. 2022 Nov 8. doi: 10.1007/s00432-022-04439-7. PMID: 36348019. Observational study. ˍ

van der Meer PB, Koekkoek JAF.
Valproic acid in glioma: Will the anticancer issue ever be solved?
Neurooncol Pract. 2022 Nov 5, 2023;10(1):1-2
. doi: 10.1093/nop/npac091. PMID: 36659971. Editorial˰ ˍ

Montégut C, Guillamo JS, Ducray F, Dehais C, Cohen-Jonathan Moyal E, Desenclos C, Petit A, Seizeur R, Bekaert L, Gaultier C, Motuo Fotso MJ, Blonski M, Frenel JS, Vauléon E, Langlois O, Noel G, Carpentier AF, Di Stefano AL, Bronnimann C, Figarella-Branger D, Chinot O, Tabouret E.
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study.
Cancers (Basel). 2022 Nov 9;14(22):5509. doi: 10.3390/cancers14225509. PMID: 36428602. Observational study. ˍ

Schebesch KM, Höhne J, Rosengarth K, Noeva E, Schmidt NO, Proescholdt M.
Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome.
Brain Spine. 2022 Nov 9;2:101690
. doi: 10.1016/j.bas.2022.101690. PMID: 36506293. Observational study. ˍ

Ali AS, Lombardo J, Niazi MZ, Miller RC, Alnahhas I, Martinez NL, Andrews DW, Judy KD, Shi W.
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study.
J Neurooncol. 2022 Nov 10. doi: 10.1007/s11060-022-04146-w. PMID: 36355259. Interventional study˰ ˍ


Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O'Brian DK, Saint-Jacques N, Coleman MP, Allemani C; CONCORD Working Group.
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3).
Neuro Oncol. 2022 Nov 10, 2022:noac217. doi: 10.1093/neuonc/noac217. PMID: 36355361. Observational study. ˍ

Hazaymeh M, Löber-Handwerker R, Döring K, Abboud T, Mielke D, Rohde V, Malinova V.
Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.
Sci Rep. 2022 Nov 10;12(1):19208
. doi: 10.1038/s41598-022-23794-6. PMID: 36357498. Observational study. ˍ

Nagane M, Ichimura K, Onuki R, Narushima D, Honda-Kitahara M, Satomi K, Tomiyama A, Arai Y, Shibata T, Narita Y, Uzuka T, Nakamura H, Nakada M, Arakawa Y, Ohnishi T, Mukasa A, Tanaka S, Wakabayashi T, Aoki T, Aoki S, Shibui S, Matsutani M, Ishizawa K, Yokoo H, Suzuki H, Morita S, Kato M, Nishikawa R.
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study.
Cancers (Basel). 2022 Nov 10;14(22):5522. doi: 10.3390/cancers14225522. PMID: 36428615. Interventional study. ˍ

Wang J, Huang Y, Zhao F, Chen J, He L, Liu Z, Pei Y, Wei Z, Li R, Ai P, Peng X.
Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis.
J Neurooncol. 2022 Nov 10. doi: 10.1007/s11060-022-04162-w. PMID: 36357822. Observational study˰ ˍ


De Lucia F, Lefebvre Y, Lemort MP.
Interest of routine MR spectroscopic techniques for differential diagnosis between radionecrosis and progression of brain tumor lesions.
Eur J Radiol Open. 2022 Nov 11;9:100449. doi: 10.1016/j.ejro.2022.100449. PMID: 36386763. Interventional study. ˍ

Saito T, Mizumoto M, Liang HK, Nakai K, Sumiya T, Iizumi T, Kohzuki H, Numajiri H, Makishima H, Tsurubuchi T, Matsuda M, Ishikawa E, Sakurai H.
Factors Involved in Preoperative Edema in High-Grade Gliomas.
Cureus. 2022 Nov 11;14(11):e31379
. doi: 10.7759/cureus.31379. PMID: 36514578. Observational study. ˍ

Nakagawa T, Kijima N, Hasegawa K, Ikeda S, Yaga M, Wibowo T, Tachi T, Kuroda H, Hirayama R, Okita Y, Kinoshita M, Kagawa N, Kanemura Y, Hosen N, Kishima H.
Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy.
Neurooncol Adv. 2022 Nov 15, 2023;5(1):vdac177
. doi: 10.1093/noajnl/vdac177. PMID: 36601313. Laboratory investigation. ˍ

Plaha P, Camp S, Cook J, McCulloch P, Voets N, Ma R, Taphoorn MJB, Dirven L, Grech-Sollars M, Watts C, Bulbeck H, Jenkinson MD, Williams M, Lim A, Dixon L, Price SJ, Ashkan K, Apostolopoulos V, Barber VS, Taylor A; FUTURE-GB collaborators, Nandi D.
FUTURE-GB: functional and ultrasound-guided resection of glioblastoma - a two-stage randomised control trial.
BMJ Open. 2022 Nov 15;12(11):e064823. doi: 10.1136/bmjopen-2022-064823. PMID: 36379652. Interventional study. ˍ

Tao Q, Zhu T, Ge X, Gong S, Guo J.
The efficacy and safety of low-dose temozolomide maintenance therapy in elderly patients with glioblastoma: a retrospective cohort study.
Ann Palliat Med. 2022 Nov [15];11(11):3513-3519
. doi: 10.21037/apm-22-1255. PMID: 36464967. Observational study. ˍ

Vázquez M, Bachmann N, Pica A, Bolsi A, De Angelis C, Lomax AJ, Weber DC.
Early outcome after craniospinal irradiation with pencil beam scanning proton therapy for children, adolescents and young adults with brain tumors.
Pediatr Blood Cancer. 2022 Nov 15, 2022:e30087. doi: 10.1002/pbc.30087. PMID: 36377685. Observational study. ˍ

Wang Q, Lin W, Liu T, Hu J, Zhu Y.
Immunological classification of glioblastoma and its prognostic implications.
Am J Transl Res. 2022 Nov 15;14(11):8009-8022
. PMID: 36505340. Laboratory investigation. ˍ